Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Merck Mexico widens Sucanon distribution network
Sucanon, an oral medication for type-2 diabetes, is a member of a class of diabetic medications called insulin sensitizers which help the body to make better usage of
Sucanon, an oral medication for type-2 diabetes, is a member of a class of diabetic medications called insulin sensitizers which help the body to make better usage of
Astellas has filed a notice of application to the Patented Medicine (Notice of Compliance) Regulations in Canada against Sandoz Canada related to the filing of an abbreviated new
The new facility will be made in 35000sqft area HCL’s Jurong Development Center in Singapore and is expected to be run under collaborations with educational and academic research
The grant will help the company in the intended dosing conversion study of CD-LD ER to IPX066 in pateints with advanced PD pateints. The company is also set
The patent applications entitled, ‘Compositions to Effect Neuronal Growth,’ include three new compounds and also cover both structure and method claims for inducing neurogenesis and the growth of
The sNDA was submitted to the FDA on 6 May 2011 by Eisai. The submission of the application was supported by the results of Phase III trial compared
The tie up aims to deliver a target list of compounds suitable for taking forward for further development. IVCC chief operating officer Tom McLean said this project joins
The results of the trial suggested that the patients treated with sarilumab in conjunction with methotrexate (MTX) improved signs and symptoms of moderate-to-severe RA compared to patients treated
The IND application seeks permission to conduct clinical trial in human non-patient volunteers. Prior to submitting the IND, the company has conducted meeting with the FDA and the
In the trial, inecalcitol was 11 times potent than a naturally active metabolite of vitamin D, calcitriol in suppressing the growth in-vitro of the human hormone-dependent prostate cancer